Skip to main content

Table 1 Clinical characteristics at baseline and CGMS features of study participants

From: Association of silent hypoglycemia with cardiac events in non-diabetic subjects with acute myocardial infarction undergoing primary percutaneous coronary interventions

Parameter

value

Subject number

164

Age (years)

53 ± 15

Males

115(70)

BMI, kg/m2

24.7 ± 4.1

LVEF, %

54.2 ± 7.4

HbA1c (%)

5.1 ± 1.0

Glycated albumin (%)

12.8 ± 4.6

Oral beta-blocker therapy(n,%)

135(82.3)

Risk factors (n,%)

 

Hyperlipidemia

61(37.2)

Hypertension

65(39.6)

Current smoking

76(46.3)

Family history

21(13)

Obesity

35(21)

CGMS parameters

 

MBG(mmol/l)

6.6 ± 0.8

MAGE (mmol/l)

2.8 ± 1.6

SDBG(mmol/l)

1.4 ± 0.5

The number of Mean episodes of hypoglycemia per patient

1.7 ± 1.8

The numberof Mean episodes of hyperglycemia per patient

2.4 ± 2.7

Mean duration of hypoglycemia per patient (h)

1.6 ± 3.0

Mean duration of hyperglycemia per patient (h)

2.5 ± 3.9

Angiographic data (n,%)

 

Single vessel

71(43.3)

Double vessels

50(30.5)

Triple vessels

43(26.2)

Main stem involved

20(12)

Multivessel

93(57)

  1. Data given as mean ± SD or n (%)
  2. BMI body mass index, LVEF left ventricularejectionfraction, HbA1c Hemoglobin A1c, MBG Mean blood glucose, MAGE the mean amplitude of glycemic excursions, SDBG the standard deviation of blood glucose values